SciELO - Scientific Electronic Library Online

SciELO - Scientific Electronic Library Online

Article References

HARRIS, Tashneem et al. Aminoglycoside: induced hearing loss in HIV-positive and HIV-negative multidrug-resistant tuberculosis patients. SAMJ, S. Afr. med. j. [online]. 2012, vol.102, n.6, pp. 363-365. ISSN 2078-5135.

    1. Wells CD, Cegielsk JP, Nelson LJ, et al HIV infection and multidrug-resistant tuberculosis: the perfect storm. J Infect Dis 2007;196(Suppl 1): S86-S107. [] [PMID:17624830] [ Links ]

    2. World Health Organization. Guidelines for the Programmatic Management of Drug-resistant Tuberculosis. Emergency Update 2008. Geneva: World Health Organization, 2008. WHO/HTM/TB/2008.402. (accessed 20 February 2010). [ Links ]

    3. Selimoglu E. Aminoglycoside-induced ototoxicity. Curr Pharm 2007;13:119-126. [][PMID:17266591] [ Links ]

    4. Moore RD, Smith CR , Lietman PS. Risk factors for the development of auditory ototoxicty in patients receiving aminoglycosides. J Infect Dis 1984;149(1):23-30. [] [PMID:6693788] [ Links ]

    5. Bardien S, Human H, Harris T, et al. A rapid method for the detection of five known mutations associated with aminoglycoside induced deafness. BMC Med Genet 2009;10:2. (accessed 30 March 2010). [ Links ]

    6. Human H, Hagen CM, Bardien S, et al. Investigation of mitochondrial sequence variants associated with aminogloycoside-induced ototoxicity in South African TB patients on aminoglycosides. Biochem Biophys Res Commun 2010;393;751-756. [] [PMID:20171168] [ Links ]

    7. Tang HY, Hutcheson T, Neill S, et al. Genetic susceptibility to aminolgycoside ototoxicity: how many are at risk? Genet Med 2002;4(5):336-339. [][PMID:12394346]. [ Links ]

    8. Lu J, Qian Y, Li Z, et al. Mitochondrial haplottypes may modulate the phenottypic manifestation of the deafness associated 12S rRNA 1555A>G mutation. Mitochondrion 2010;10(1):69-81. [][PMID:19818876] [ Links ]

    9. Duggal P, Sarkar M. Audiological monitoring of multi-drug resistant tuberculosis patients on aminoglycoside treatment with long term follow-up. BMC Ear Nose Throat Disorders 2007;7:2. (accessed 30 March 2010). [][PMID:17997841] [ Links ]

    10. Torun T, Gungor G, Ozmen I, et al. Side effects associated with the treatment of multi-drug resistant tuberculosis. Int J Tuberc Lung Dis 2005;9(12):1373-1377. [PMID:16468160] [ Links ]

    11. Khoza-Shangase K. Highly active anttiretroviral therapy: Does it sound toxic? J Pharm Bioall Sci 2011;3:142-153. [] [PMID:21430965] [ Links ]

    12. Campbell K. Audiologic monitoring for ototoxicity. In: Roland P, Rutka J, eds. Ototoxicity. Hamilton, Canada: B C Decker Publishers, 2004:153-160. [ Links ]

    13. Swart S. Draft Report: Modernisation of Audiology Sevices, Western Cape 2010. Cape Town: Department of Health, Western Cape, 2010:41-46. [ Links ]

    14. Khoza-Shangase K, Mupawose A, Mlangeni NP. Ototoxic effects of tuberculosis treatments: How aware are patients? AJPP 2009;3(8):391-399. (accessed 7 March 2012). [ Links ]